+ |
LMP1 | down-regulates activity
sumoylation
|
IRF7 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266951 |
|
|
Homo sapiens |
HEK-293T Cell |
pmid |
sentence |
22951831 |
One mechanism by which LMP1 regulates cellular activation is through the induction of protein posttranslational modifications. We have now identified a specific target of LMP1-induced sumoylation, interferon regulatory factor 7 (IRF7). We hypothesize that during EBV latency, LMP1 induces the sumoylation of IRF7, limiting its transcriptional activity and modulating the activation of innate immune responses. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | EBV infection |
+ |
LMP1 | down-regulates quantity by repression
transcriptional regulation
|
TLR9 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266804 |
|
|
Homo sapiens |
RPMI-8226 Cell |
pmid |
sentence |
20980631 |
We determined that the EBV oncoprotein latent membrane protein 1 (LMP1) is a strong inhibitor of TLR9 transcription. These data show that the oncoprotein LMP1 downregulates TLR9 promoter activity in B cells. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | EBV infection |
+ |
LMP1 | up-regulates activity
|
NfKb-p65/p50 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267616 |
|
|
Homo sapiens |
|
pmid |
sentence |
26428373 |
Soon, it has been recognized that TES1 and 2 coincide with two regions named C-terminal activating regions (CTAR) 1 and 2, respectively, that are responsible for interaction of LMP1 with cellular signaling molecules. Early studies revealed that both CTAR1 and CTAR2 contribute to the activation of NF-κB, Later, it became evident that CTAR1 primarily activates the non-canonical NF-κB pathway, while CTAR2 is responsible for canonical NF-κB activation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | EBV infection |
+ |
LMP1 | up-regulates activity
|
PI3K |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267618 |
|
|
Homo sapiens |
|
pmid |
sentence |
26428373 |
Activation of the PI3-K/AKT pathway was first linked to LMP1 in the year 2003. Although it is still unclear whether this interaction is direct, expression of LMP1 CTAR1 caused (i) an enrichment of the PI3-K substrate phosphatidylinositol-3,4,5-trisphosphate (PIP3) in the plasma membrane and (ii) the phosphorylation and activation of AKT kinase, also known as protein kinase B, at serine 473. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | EBV infection |
+ |
LMP1 | up-regulates activity
|
JNK |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-267617 |
|
|
Homo sapiens |
|
pmid |
sentence |
26428373 |
AP1 is a dimeric transcription factor composed of members of the Jun and Fos protooncoprotein families. AP1 was found induced by LMP1 through the JNK signaling cascade, involving JNK1-mediated phosphorylation and activation of c-Jun. JNK1 activation critically relies on CTAR2 and its P379VQLSYY motif. It has long been unclear which signaling mediators at CTAR2 are involved in JNK activation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | EBV infection |
+ |
LMP1 | up-regulates activity
binding
|
UBE2I |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266838 |
|
|
Homo sapiens |
HEK-293T Cell |
pmid |
sentence |
22951831 |
One mechanism by which LMP1 regulates cellular activation is through the induction of protein posttranslational modifications. We have now identified a specific target of LMP1-induced sumoylation, interferon regulatory factor 7 (IRF7). We hypothesize that during EBV latency, LMP1 induces the sumoylation of IRF7, limiting its transcriptional activity and modulating the activation of innate immune responses. We recently documented that LMP1 induces a third major protein modification by physically interacting with the SUMO-conjugating enzyme Ubc9 through CTAR3 and inducing the sumoylation of cellular proteins in latently infected cells. we identified that IRF7 is sumoylated at lysine 452. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | EBV infection |